Transgenic neuronal nitric oxide synthase expression induces axotomy-like changes in adult motoneurons
- 15 September 2010
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 588 (18), 3425-3443
- https://doi.org/10.1113/jphysiol.2010.195396
Abstract
Dysregulation of protein expression, function and/or aggregation is a hallmark of a number of neuropathological conditions. Among them, upregulation and/or de novo expression of the neuronal isoform of nitric oxide (NO) synthase (nNOS) commonly occurs in diverse neurodegenerative diseases and in axotomized motoneurons. We used adenoviral (AVV) and lentiviral (LVV) vectors to study the effects of de novo nNOS expression on the functional properties and synaptic array of motoneurons. AVV-nNOS injection into the genioglossus muscle retrogradely transduced neonatal hypoglossal motoneurons (HMNs). Ratiometric real-time NO imaging confirmed that transduced HMNs generated NO gradients in brain parenchyma (space constant: similar to 12.3 mu m) in response to a glutamatergic stimulus. Unilateral AVV-nNOS microinjection in the hypoglossal nucleus of adult rats induced axotomy-like changes in HMNs. Specifically, we found alterations in axonal conduction properties and the recruitment order of motor units and reductions in responsiveness to synaptic drive and in the linear density of synaptophysin-positive puncta opposed to HMN somata. Functional alterations were fully prevented by chronic treatment with nNOS or soluble guanylyl cyclase inhibitors. Synaptic and functional changes were also completely avoided by prior intranuclear injection of a neuron-specific LVV system for miRNA-mediated nNOS knock-down (LVV-miR-shRNA/nNOS). Furthermore, synaptic and several functional changes evoked by XIIth nerve injury were to a large extent prevented by intranuclear administration of LVV-miR-shRNA/nNOS. We suggest that nNOS up-regulation creates a repulsive NO gradient for synaptic boutons underlying most of the functional impairment undergone by injured motoneurons. This further strengthens the case for nNOS targeting as a plausible strategy for treatment of peripheral neuropaties and neurodegenerative disorders.This publication has 77 references indexed in Scilit:
- Axonal Transport Defects in Neurodegenerative DiseasesJournal of Neuroscience, 2009
- Proteome of synaptosome‐associated proteins in spinal cord dorsal horn after peripheral nerve injuryProteomics, 2009
- Reporting ethical matters in The Journal of Physiology: standards and adviceThe Journal of Physiology, 2009
- Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell DeathJournal of Neuroscience, 2008
- Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivoBMC Biotechnology, 2008
- Early alterations in the electrophysiological properties of rat spinal motoneurones following neonatal axotomyThe Journal of Physiology, 2007
- The corticostriatal pathway in Huntington's diseaseProgress in Neurobiology, 2007
- Inactivation of nitric oxide by rat cerebellar slicesThe Journal of Physiology, 2006
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- 7-Nitro indazole Derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthaseLife Sciences, 1995